Order.co Achieves SOC 2 Type II Compliance, Reinforcing Commitment to Data Security and Operational Excellence Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary Announces Expansion of Ztlido® Managed Care Coverage for Additional 33 Million Lives
PALO ALTO, Calif., Aug. 19, 2021 (GLOBE NEWSWIRE) — Scilex Holding Company (SCILEX), a subsidiary…
Heat Biologics Announces New Additions to Biothreat Advisory Board
Former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs, Andrew C. Weber Expert…
Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome
Company announcement – No. 52 / 2021 Zealand Pharma Announces First Patient Dosed in EASE-SBS…
Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Humacyte Highlights Robust Expanded Access Program and Patient Testimonial for Human Acellular Vessels
On October 5th, 2020, Devin Barnett was critically injured by a crane while working at…
Otonomy Appoints Jill Broadfoot to Board of Directors
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…
Adamis Highlights National Institutes of Health (NIH) Article Entitled, “Tempol: A Potential Home Treatment for COVID-19”
NIH Researchers Contend that Tempol can be taken orally and may stop the replication of…
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
Collaboration to evaluate NEObody™ product candidate, ADG106, in combination with KEYTRUDA® for patients with advanced…
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or the “Company”)…
Plus Therapeutics Presents Data from Preclinical Study of Rhenium-186 Nanoliposome in Leptomeningeal Metastases and Plans for Further Evaluation with Upcoming Phase 1 Clinical Trial
Positive data to support FDA IND application for the clinical evaluation of Rhenium-186 Nanoliposome (186RNL)…
Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress
BALA CYNWYD, Pa., Aug. 19, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Alladapt Initiates Buildout of New Manufacturing Facility for Production of Novel, Investigational Oral Immunotherapeutic Designed to Address a Broad Range of Food Allergies
ADP101 is a singular optimized, pharmaceutical-grade oral immunotherapy candidate currently in a Phase 1/2 clinical…
MediPharm Labs Australia Receives Government Grant to Assist with International Expansion
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s…
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Debuted as Publicly Traded Company and Raised $100 Million in Gross Proceeds to Fund Liquid…
On the offer to purchase AS “Olainfarm” shares – announcement by AS “AB CITY”
With the following AS “Olainfarm” informs that on August 19, 2021 it has received announcement…
Onit Speeds Up End-to-End NDA Management by 70% with Automate NDA
Solution Combines AI, Automation and Self-Service to Streamline the High-Touch Non-Disclosure Agreement Process for In-House…
Avid Expands MediaCentral Integration with Third-Party Newsroom Computer Systems
New OpenMedia integration enables news production teams to accelerate workflows and collaborate remotely with the…
Dykema Selects FileTrail GPS for Information Governance
Leading law firm to implement FileTrail for records management and retention CHICAGO, Aug. 19, 2021…
Indio Adoption Grows by 37% Year over Year
Growth driven by agency demand for a streamlined application and submission process UNIVERSITY PARK, Ill.,…
For the Second Year in a Row, Inc. 5000 Names CloudBolt Software One of the Fastest-Growing Private Companies in America
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) — Inc. magazine today revealed it has placed…